Strategies based on evidence to rationalize the high cost drugs national list in the Dominican Republic

Journal Article
  • E. Barillas
  • C. Valdez
  • E. Narvaez
  • G. Vasquez
Value in Health
Nov. 2015; 8 (7): A657. DOI: 10.1016/j.jval.2015.09.2376.

In 2014, the budget for high cost drugs in the Dominican Republic was USD 107 million, accounting for 51% of the Ministry of Health (MoH) budget for medicines. Resources allocated for the 2015 budget were USD 49 million, leaving a shortfall of USD 62 million. The MoH requested technical assistance from the USAID-funded SIAPS project to conduct an evidence based analysis of the 98 products included in the list.

Printer Friendly VersionPDF